Day One Biopharmaceuticals Inc (OQ:DAWN)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for DAWN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET October 7th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 5/22 Oct 4/22 Grant Julie Papanek Indirect Ownership Common Stock S - Open market or private sale -5,000 $20.00
Oct 5/22 Oct 3/22 York Charles N II Direct Ownership Common Stock S - Open market or private sale -10,000 $20.05
Oct 5/22 Oct 3/22 Grant Julie Papanek Indirect Ownership Common Stock S - Open market or private sale -5,000 $20.06
Oct 5/22 Oct 3/22 Blackman Samuel C. Direct Ownership Common Stock S - Open market or private sale -10,000 $19.99
Oct 5/22 Oct 3/22 Bender Jeremy Direct Ownership Common Stock S - Open market or private sale -12,500 $20.05
Sep 22/22 Sep 21/22 Canaan XI L.P. Direct Ownership Common Stock J - Other transaction -1,500,000  
Sep 22/22 Sep 21/22 Canaan XI L.P. Direct Ownership Common Stock S - Open market or private sale -6,106 $19.29
Sep 22/22 Sep 21/22 Canaan XI L.P. Direct Ownership Common Stock S - Open market or private sale -607,497 $18.54
Sep 22/22 Sep 21/22 Grant Julie Papanek Indirect Ownership Common Stock J - Other transaction -1,500,000  
Sep 22/22 Sep 21/22 Grant Julie Papanek Indirect Ownership Common Stock S - Open market or private sale -6,106 $19.29
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for DAWN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET October 7th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 5/22 Oct 3/22 York Charles N II Direct Ownership Common Stock S - Open market or private sale -10,000 $20.05
Oct 5/22 Oct 4/22 Grant Julie Papanek Indirect Ownership Common Stock S - Open market or private sale -5,000 $20.00
Oct 5/22 Oct 3/22 Grant Julie Papanek Indirect Ownership Common Stock S - Open market or private sale -5,000 $20.06
Oct 5/22 Oct 3/22 Blackman Samuel C. Direct Ownership Common Stock S - Open market or private sale -10,000 $19.99
Oct 5/22 Oct 3/22 Bender Jeremy Direct Ownership Common Stock S - Open market or private sale -12,500 $20.05
Sep 22/22 Sep 21/22 Canaan XI L.P. Direct Ownership Common Stock J - Other transaction -1,500,000  
Sep 22/22 Sep 21/22 Canaan XI L.P. Direct Ownership Common Stock S - Open market or private sale -6,106 $19.29
Sep 22/22 Sep 21/22 Canaan XI L.P. Direct Ownership Common Stock S - Open market or private sale -607,497 $18.54
Sep 22/22 Sep 21/22 Grant Julie Papanek Indirect Ownership Common Stock J - Other transaction -1,500,000  
Sep 22/22 Sep 21/22 Grant Julie Papanek Indirect Ownership Common Stock S - Open market or private sale -6,106 $19.29
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $DAWN

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.